In vivo Lesion Index (LSI) validation in percutaneous radiofrequency catheter ablation

J Cardiovasc Electrophysiol

7 Aprile Apr 2022 one month ago
  • Fassini G, Tondo C

Lesion Index (LSI) has been developed to predict lesion efficacy during radiofrequency (RF) catheter ablation. However, its value in predicting lesions size has still to be established. The aim of our study was to assess the lesions size reproducibility for prespecified values of LSI reached during RF delivery in an in vivo beating heart.

Reference: In vivo Lesion Index (LSI) validation in percutaneous radiofrequency catheter ablation. Themistoclakis S, Calzolari V, De Mattia L, China P, Russo AD, Fassini G, Casella M, Caporaso I, Indiani S, Addis A, Basso C, Della Barbera M, Thiene G, Tondo C. J Cardiovasc Electrophysiol. 2022 Mar 9.

Go to PubMed